Michael Kim bought $367K of Claritev (CTEV)
Executed Nov 17 2025, disclosed Nov 18 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Nov 18 2025), the stock returned -1.5% (delay-adjusted); from the execution session (Nov 17 2025), -9.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
Michael Kim (SVP, Chief Information Officer) filed 3 Form 4 reports in the trailing twelve months (3 purchases, 0 sales), most often in Claritev Corporation (CTEV). Across 3 priced purchase filings, the average 21-session return was +0.3% from execution and +7.2% from disclosure (delay-adjusted; derived). The largest single filing was $429K of CTEV (30,000 sh × $14.30, as filed), executed Feb 27.
Healthcare · Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, a…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→15,000 sh × $16.50
Exec Mar 12
Filed Mar 16 · 8:42 AM ET CTEVPURCHASE Claritev Corporation $429K
30,000 sh × $14.30
Exec Feb 27
Filed Mar 2 · 5:01 PM ET